pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 26·1 min read
save

New York law adds recording safeguard to medical aid in dying, sparking ethical debate

Aug 26, 2026·read at STAT ↗RegulatoryNeutral

New York has enacted a law that permits terminally ill residents with six months or less to obtain medication for self-directed death. A distinctive feature of the legislation is that patients must record their oral request on audio or video before receiving the drug.

The recording requirement is meant to provide clear evidence that the decision is truly the patient’s and to guard against undue influence.

Supporters of medical aid in dying say that offering the option respects autonomy and gives patients control over the end of their lives.

Philosopher David Velleman, however, warns that simply having the choice can be harmful. He argues that the existence of an option may create pressure or distress even when no external coercion is present.

The new safeguard highlights the ethical complexity of assisted-suicide policies, suggesting that more choice does not automatically translate into greater well-being.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Medical aid in dying and the burden of choosing to live”

read at STAT ↗
1,062 words · retrieved Aug 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Small Molecule2Oncology

related stories

  • May 6MANEUVER Trial Underscores Potential Paradigm Shift Toward Targeted Approaches in TGCTonclive
  • May 6Dr McGregor on the DAD-IO Trial of Sacituzumab Govitecan and EV in Metastatic Urothelial Carcinomaonclive
  • May 6Neoadjuvant T-DXd Followed by THP Improves RCB in HER2+ Breast Canceronclive
  • May 6Dr Lee on Research Collaborations Studying PD-L1 as a Biomarker in NSCLConclive
  • May 6Dr Chari on Frontline Combinations and Transplant Approaches in Multiple Myelomaonclive